Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Shares Issued Shares Outstanding Shares Outstanding

Ratios

Beta Bionics (BBNX) Shares Issued (2024 - 2026)

Beta Bionics' Shares Issued history spans 3 years, with the latest figure at $623000.0 for Q1 2026.

On a quarterly basis, Shares Issued fell 99.68% to $623000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was -$190.0 million, a 197.21% decrease, with the full-year FY2025 number at $4.8 million, up 5244.94% from a year prior.
Shares Issued hit $623000.0 in Q1 2026 for Beta Bionics, up from -$10.8 million in the prior quarter.
Over the last five years, Shares Issued for BBNX hit a ceiling of $195.4 million in Q1 2025 and a floor of -$195.3 million in Q2 2025.
Historically, Shares Issued has averaged $683625.0 across 3 years, with a median of $41500.0 in 2024.
The widest YoY moves for Shares Issued: up 3257066.67% in 2025, down 29381.08% in 2025.
Tracing BBNX's Shares Issued over 3 years: stood at $37000.0 in 2024, then plummeted by 29381.08% to -$10.8 million in 2025, then surged by 105.75% to $623000.0 in 2026.
Business Quant data shows Shares Issued for BBNX at $623000.0 in Q1 2026, -$10.8 million in Q4 2025, and $15.5 million in Q3 2025.